Elizabeth A. Nevins

Elizabeth Nevins is an associate in the Corporate Practice Group in the firm's Dallas office, and a member of the Healthcare team.

Areas of Practice 

Elizabeth earned her J.D. from SMU Dedman School of Law in Dallas, Texas, where she graduated with honors. During law school, she served as an Articles Editor for the SMU Law Review, was named a Tsai Scholar for the Tsai Center for Law, Science and Innovation, volunteered for the COVID-19 legal helpline, and worked as a research assistant studying the intricacies of bioethics, healthcare regulation, and health inequities. She received a B.S. in Biomedical Sciences with a minor in Spanish from Texas A&M University, where she also graduated with honors.

Prior to law school, Elizabeth worked at UT Southwestern Medical Center in the Biochemistry department as a research technician utilizing genetic modification techniques to help study metabolic processes and discover pro-neurogenic chemicals to tackle neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS.  

Articles

Healthcare Law Blog Posts

• "Women’s Health on the Ballot in November: What the Election Could Mean for Reproductive Care and Beyond," October 4, 2024

• "Supreme Court Unanimously Preserves Access to Mifepristone," June 14, 2024
• "U.S. Department of Labor Rescinds Trump-Era Rule on Association Health Plans (AHPs)," May 15, 2024

• "CMS Issues CY2025 Medicare Advantage and Part D Final Rule," April 15, 2024

• "HHS & DOJ FY 2022 Enforcement Targeted Fraud in COVID-19, Telemedicine, Opioid and Prescription Drugs, and Substance Use Treatment Centers, Among Other Initiatives," December 1, 2023

• "CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule," November 13, 2023

• "Fifth Circuit Rules to Reinstate Abortion Pill Restrictions," August 17, 2023
• "Access to Abortion Pill on the Precipice: A Deep Dive into the Federal Court Rulings that will Decide the Fate of Mifepristone," June 15, 2023

• "HHS OCR Delivered Annual Reports to Congress," April 17, 2023

• "Access to Abortion Pill in Limbo: Navigating the Intricacies of Conflicting Federal Court Rulings in Texas and Washington State," April 14, 2023

• "HHS Proposes Health Insurance Market Reforms for 2024," January 4, 2023